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Background: Estimated glomerular ﬁltration rate (eGFR) is one of the most
important guidelines in deciding the optimal timing of dialysis initiation. In the
present study, we calculated the eGFR at the time of hemodialysis (HD) initiation
using 5 commonly used equations to relate them with clinical and laboratory
characteristics of the patients and to evaluate which of these equations best
deﬁne the eGFR at HD initiation.
Methods: We retrospectively analyzed 409 end-stage renal disease patients who
were newly started on HD treatment in our institution. The eGFR was calculated
using the CockcrofteGault equation, the CockcrofteGault equation corrected for
body surface area, the Modiﬁcation of Diet in Renal Disease (MDRD) equation, the
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, and the
Nankivell equation.
Results: The mean eGFRs at HD start were signiﬁcantly different across the equa-
tions. The mean eGFR was 7.8 mL/min for the corrected CockcrofteGault equation,
7.7 mL/min for the CockcrofteGault equation, 6.2 mL/min/1.73 m2 for the MDRD
equation, and 5.6 mL/min/1.73 m2 for the CKD-EPI equation. The corrected Cockcroft
eGault, the MDRD, and the CKD-EPI equations were well correlated with all CKD-
speciﬁc complications including hypertension, anemia, hyperkalemia, metabolic
acidosis, hypocalcemia, hyperphosphatemia, and hyperparathyroidism. The mean
eGFR calculated by the corrected CockcrofteGault equation showed the lowest co-
efﬁcient of variation among all the equations.
Conclusions: The eGFR at HD initiation are signiﬁcantly different according to the
used eGFR equations, and the corrected CockcrofteGault equation may be the best
in deﬁning the eGFR at HD initiation.
Copyright © 2015. The Korean Society of Nephrology. Published by Elsevier Ltd. This
is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).hrology, Ajou University
tong-gu, Suwon 443-721,
iety of Nephrology. Published
y-nc-nd/4.0/).Introduction
Dialysis now offers life-sustaining treatment to approxi-
mately 2 million end-stage renal disease (ESRD) patients
worldwide [1]. The guidelines across many regions in the
world recommend the initiation of dialysis based on esti-
mated glomerular ﬁltration rate (eGFR). In fact, the guidelines
of National Kidney Foundation Kidney Disease Outcomesby Elsevier Ltd. This is an open access article under the CC BY-NC-ND
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dian guidelines [5], recommend the initiation of dialysis
when the eGFR is less than 10e15 mL/min. However, recent
studies showed that the early dialysis initiation as recom-
mended by these guidelines was not associated with an
improvement in clinical outcomes, as compared to the late-
start dialysis [6e9].
The Initiating Dialysis Early and Late (IDEAL) study is a
prospective, multicenter, randomized, controlled trial to
compare outcomes in patients starting dialysis with a higher
versus lower eGFR, where the mean eGFR was 12.0 mL/min for
the patients who started dialysis early and 9.8 mL/min for those
who started dialysis late with the use of the corrected Cock-
crofteGault equation and 9.0 mL/min and 7.2 mL/min, respec-
tively, with the use of the Modiﬁcation of Diet in Renal Disease
(MDRD) equation [6]. Interestingly, the differences between the
early-start and the late-start groups (2.2 and 1.8 mL/min) were
smaller than the differences created by the 2 equations within
the group (3.0 and 2.6 mL/min), which indicates that the
discrepancy of the mean eGFR between the 2 equations is too
big for the equations to be used interchangeably.
In the present study, we calculated the eGFR at the time of
hemodialysis (HD) initiation using 5 commonly used equations
including the CockcrofteGault equation, the CockcrofteGault
equation corrected for body surface area, the MDRD equation,
the Chronic Kidney Disease Epidemiology Collaboration (CKD-
EPI) equation, and the Nankivell equation to relate them with
clinical and laboratory characteristics of the patients and to




We retrospectively analyzed ESRD patients who were
newly started on HD between January 2010 and December
2012 in our institution. Patients were included if they were 18
years or older and started HD for the ﬁrst time. Data regarding
clinical and demographic characteristics including age, gender,
height, weight, systolic and diastolic blood pressures, causes of
ESRD, and comorbidities including diabetes mellitus (DM),
hypertension, cardiovascular disease (CVD), and congestive
heart failure (CHF) were collected from the medical records.
DM was deﬁned based on the presence of documented or self-
reported history of diabetes or diabetic retinopathy or the
presence of diabetic medications in patients' prescription re-
cords. Hypertension was deﬁned in the same way as in DM.
This study was approved by the Institutional Review Board of
our institution.
Laboratory data
Blood urea nitrogen, creatinine (Cr), bone mineral markers
(intact parathyroid hormone, phosphorus, and total calcium),
a nutritional marker (albumin), metabolic acidosis markers
(bicarbonate), and anemia markers (hemoglobin) were
recorded. All laboratory data except intact parathyroid hor-
mone levels were obtained within 1 day before the start of
HD. Intact parathyroid hormone levels were obtained within
3 months before the start of HD or within 3 days after the
start of HD.Estimated glomerular ﬁltration rate
For eGFR, we used 5 equations as follows: CockcrofteGault
equation [10], [140 e age (years)]  [weight (kg)]  (0.85 if
female)/[72  serum Cr (sCr, mg/dL)]; CockcrofteGault equa-
tion corrected for body surface area, [140 e age (years)] 
[weight (kg)]  (0.85 if female)/[72  sCr (mg/dL)]  1.73/body
surface area (m2); MDRD equation [11], 186.3  [sCr (mg/
dL)]e1.154  [age (years)]e0.203  (0.742 if female); CKD-EPI
equation [12], 141  min [Scr (mg/dL)/k,1]a  max [Scr (mg/
dL)/k,1]e1.209  0.993age (years)  1.018 (if female)  1.159 (if
black), where k is 0.7 for females and 0.9 for males, a is e0.329
for females and e0.411 for males, min indicates the minimum
of Scr/k or 1, and max indicates the maximum of Scr/k or 1;
Nankivell equation [13], [6.7/sCr (mmol/L)] þ [weight (kg)/4] e
[serum urea (mmol/L)/2] e [100/height (m)2] þ (35 if males
and 25 if females).
Statistical analysis
Continuous variables are described as means with standard
deviation and categorical variables as proportions. Differences
between the subgroups were assessed using chi-square tests
for categorical variables and Student's t tests for continuous
variables. The coefﬁcient of variation (CV) was calculated as the
percent ratio of the standard deviation to the mean. Correla-
tions between variables were assessed by Pearson's correlation
tests. Values of P < 0.05 were considered statistically signiﬁ-
cant. The analyses were performed using the Statistical Package
for Social Sciences (SPSS for Windows 18.0, SPSS Inc., Chicago,
IL, USA).
Results
Between January 2010 and December 2012, 1,369 patients
who were new to our HD unit were reviewed, and of these,
660 patients were excluded because they had started HD
previously in other centers. Other excluded patients were 249
who received HD for acute kidney injury, 17 who received
pre-emptive HD for kidney transplantation, 11 who returned
to HD after renal allograft failure, and 23 who switched to HD
from peritoneal dialysis. Finally, 409 patients who started
maintenance HD for ESRD were included in the present
analysis. Table 1 summarized the patients' demographics and
the causes of ESRD. The mean age was 58 years, and 52.6% of
the patients were men. Comorbidities were common, partic-
ularly hypertension (81.9%) and DM (52.8%). The most com-
mon causes of ESRD were diabetic nephropathy (48.7%),
followed by biopsy-proven glomerulonephritis (11.7%). The
mean eGFR at the start of HD was signiﬁcantly different
across the different equations (Table 2). The highest mean
eGFR was derived from the corrected CockcrofteGault equa-
tion (7.8 ± 3.6 mL/min/1.73 m2) followed by the Cock-
crofteGault (7.7 ± 3.8 mL/min), MDRD (6.2 ± 3.4 mL/min/1.73
m2), CKD-EPI (5.6 ± 3.2 mL/min/1.73 m2), and ﬁnally the
Nankivell equation (0.10 ± 12.74 mL/min/1.73 m2; Table 2). CV
of each eGFR was used to evaluate the extent of variability in
relation to the mean eGFR. The results showed that the CV of
the corrected CockcrofteGault equation (46.0%) was the
smallest among the included equations, whereas the Nanki-
vell equation showed the biggest CV (127.4%) despite its
lowest eGFR value (Table 2).
Table 1. Baseline characteristics of the patients (N ¼ 409)
Characteristics Mean ± SD
Age (y) 58.6 ± 14.6
Male gender, n (%) 215 (52.6)
Weight (kg) 63.2 ± 12.7
BMI (kg/m2) 24.3 ± 9.1
Systolic BP (mmHg) 153.2 ± 25.4
Diastolic BP (mmHg) 81.6 ± 16.2
Hypertension, n (%) 335 (81.9)
CVD/CHF, n (%) 79 (19.3)
Causes of renal failure, n (%)
Diabetic nephropathy 197 (48.2)
Chronic glomerulonephritis* 48 (11.7)
Polycystic kidney disease 13 (3.2)
Unknowny 130 (31.7)
Miscellaneous 21 (5.1)
Hemoglobin (g/dL) 8.5 ± 1.7
BUN (mg/dL) 97.4 ± 67.7
Creatinine (mg/dL) 10.3 ± 5.1
Sodium (mmol/L) 136.7 ± 5.5
Potassium (mmol/L) 5.1 ± 1.1
Bicarbonate (mmol/L) 15.8 ± 4.6
Calcium (mg/dL) 7.5 ± 1.3
Phosphorus (mg/dL) 6.4 ± 2.2
Albumin (g/dL) 3.5 ± 0.6
iPTH (pg/dL)z 237.9 ± 173.6
BMI, body mass index; BP, blood pressure; BUN, blood urea nitrogen;
CHF, congestive heart failure; CVD, cardiovascular disease; iPTH, intact
parathyroid hormone; SD, standard deviation.
* Included are biopsy-proven glomerulonephritis.
y Included are clinically suspected chronic glomerulonephritis without
biopsy.
z N ¼ 268.
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CKD-speciﬁc complications including hypertension, anemia,
hyperkalemia, metabolic acidosis, hypocalcemia, hyper-
phosphatemia, and hyperparathyroidism. We found that the
corrected CockcrofteGault, the MDRD, and the CKD-EPITable 2. Comparisons of mean eGFR derived from different equations
Mean ± SD CV, % Range
C-G (mL/min) 7.7 ± 3.8 49.5 1.9e2
Corrected C-G (mL/min/1.73 m2) 7.8 ± 3.6 46.0 1.9e3
MDRD (mL/min/1.73 m2) 6.2 ± 3.4 54.5 1.4e2
CKD-EPI (mL/min/1.73 m2) 5.6 ± 3.2 56.5 1.1e2
Nankivell (mL/min/1.73 m2) 0.10 ± 12.74 127.4 e54.1e3
C-G, CockcrofteGault; CKD-EPI, Chronic Kidney Disease Epidemiology Collabo
rate; MDRD, Modiﬁcation of Diet in Renal Disease; SD, standard deviation.
Table 3. Relationships between eGFR- and CKD-speciﬁc complications
SBP DBP Hb
C-G e0.073 e0.070 0.161** e0.1
Corrected C-G e0.115* e0.110* 0.179** e0.1
MDRD e0.133** e0.201** 0.204** e0.2
CKD-EPI e0.133** e0.178** 0.198** e0.2
Nankivell 0.091 0.039 0.161** e0.0
Pearson's correlation coefﬁcient, *P < 0.05, **P < 0.01.
Ca, serum total calcium; C-G, CockcrofteGault; CKD, chronic kidney dis
DBP, diastolic blood pressure; eGFR, estimated glomerular ﬁltration rate; H
K, potassium; MDRD, Modiﬁcation of Diet in Renal Disease; P, inorganic phoequations showed signiﬁcant correlations with all categories
of CKD complications, suggesting that these equations are
better than the others in reﬂecting the clinical status of the
patients (Table 3). In contrast, the eGFR from the Nankivell
equation showed a paradoxical relationship with hypertension
and with serum calcium levels (Table 3), suggesting that this
equation, derived from kidney transplant recipients, poorly
reﬂects the clinical status of the advanced CKD patients.
The reasons to start HD were uremia (progressive azotemia,
anorexia, nausea, fatigue, pericarditis, and mental change;
54.7%), ﬂuid overload (38.4%), hyperkalemia (3.9%), and meta-
bolic acidosis (2.9%).
In addition, we analyzed the data according to the presence
of DM that accounted for 52.8% of the patients. DM patients
were signiﬁcantly older and had a higher incidence of CVDs/
CHF than non-DM patients (Table 4). DM patients started HD at
signiﬁcantly higher eGFR levels than non-DM patients; how-
ever, DM patients were signiﬁcantly better in metabolic
acidosis, hyperphosphatemia, and hyperparathyroidism
(Table 4). Among the reasons for HD, uremia accounted for
48.1% in DM and 61.6% in non-DM patients, whereas ﬂuid
overload accounted for 44.9% in DM and 31.4% in non-DM pa-
tients, indicative of a higher incidence of ﬂuid overload in DM
patients (Table 4).
Finally, we analyzed the data after subgrouping the patients
into the outpatient clinic group and the emergency room (ER)
group according to the places where the decisions on HD were
made. Of all the patients, 59.2% started HD through clinic
visits and the remaining 40.8% started HD in the ER. Contrary to
our expectation, both groups were comparable in eGFR; how-
ever, they had differing reasons to start HD. The most common
cause for the ER group was ﬂuid overload (48.5%) in contrast to
uremia (66.5%) for the clinic group (Table 5). Hyperkalemia and
metabolic acidosis were signiﬁcantly more severe in the ER
group, as compared with the clinic group (Table 5).P
C-G Corrected C-G MDRD CKD-EPI Nankivell
9.1 0.002 <0.001 <0.001 <0.001




ration; CV, coefﬁcient of variation; eGFR, estimated glomerular ﬁltration
K HCO3 Ca P iPTH
61** 0.300** 0.135** e0.399** e0.203**
82** 0.343** 0.187** e0.461** e0.221**
03** 0.375** 0.242** e0.549** e0.272**
06** 0.375** 0.232** e0.532** e0.259**
95 0.241** e0.014 e0.368** e0.188**
ease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration;
b, hemoglobin; HCO3, bicarbonate; iPTH, intact parathyroid hormone;
sphate; SBP, systolic blood pressure.
Table 4. Comparisons of clinical and laboratory characteristics






Age (y) 61.1 ± 11.5 55.7 ± 17.0 <0.001
Male gender, n (%) 109 (50.5) 105 (55.0) 0.363
Weight (kg) 63.8 ± 11.1 62.3 ± 14.2 0.237
BMI (kg/m2) 25.1 ± 11.9 23.4 ± 4.0 0.067
Systolic BP (mmHg) 154.2 ± 24.1 151.9 ± 30.0 0.347
Diastolic BP (mmHg) 78.2 ± 15.0 85.4 ± 16.8 <0.001
CVD/CHF, n (%) 58 (26.9) 21 (10.88) <0.001
Hemoglobin (g/dL) 8.6 ± 1.6 8.5 ± 1.8 0.756
BUN (mg/dL) 93.0 ± 84.0 102.8 ± 42.3 0.147
Creatinine (mg/dL) 9.0 ± 3.71 11.9 ± 5.9 <0.001
Sodium (mmol/L) 136.6 ± 5.1 136.7 ± 5.9 0.626
Potassium (mmol/L) 5.1 ± 1.1 5.1 ± 1.1 0.913
Bicarbonate (mmol/L) 16.4 ± 4.4 15.2 ± 5.1 0.018
Calcium (mg/dL) 7.5 ± 1.1 7.6 ± 1.5 0.496
Phosphorus (mg/dL) 6.0 ± 1.9 6.7 ± 2.4 0.002
Albumin (g/dL) 3.4 ± 0.5 3.6 ± 0.6 <0.001
iPTH (pg/dL) 216.9 ± 157.5 260.2 ± 188.1 0.042
eGFR
C-G 8.5 ± 4.2 6.7 ± 3.0 <0.001
Corrected C-G 8.6 ± 4.0 6.9 ± 2.8 <0.001
MDRD 6.9 ± 3.6 5.4 ± 2.9 <0.001
CKD-EPI 6.2 ± 3.5 4.8 ± 2.6 <0.001
Nankivell 2.0 ± 11.9 e2.2 ± 13.3 0.001
Reasons to start HD, n (%) 0.031
Fluid overload 97 (44.9) 60 (31.4)
Uremia 104 (48.1) 119 (61.6)
Hyperkalemia 11 (5.1) 5 (2.6)
Metabolic acidosis 4 (1.9) 7 (3.7)
BMI, body mass index; BP, blood pressure; BUN, blood urea nitrogen;
C-G, CockcrofteGault; CHF, congestive heart failure; CKD-EPI, Chronic
Kidney Disease Epidemiology Collaboration; CVD, cardiovascular dis-
ease; DM, diabetes mellitus; eGFR, estimated glomerular ﬁltration rate;
HD, hemodialysis; iPTH, intact parathyroid hormone; MDRD, Modiﬁca-
tion of Diet in Renal Disease.
Table 5. Comparisons of clinical and laboratory characteristics






Age (y) 56.7 ± 14.3 61.3 ± 14.6 0.002
Male gender, n (%) 123 (50.8) 92 (55.1) 0.396
Weight (kg) 62.8 ± 11.5 63.9 ± 14.2 0.405
BMI (kg/m2) 24.4 ± 11.2 24.1 ± 4.5 0.767
DM, n (%) 120 (49.8) 96 (57.8) 0.110
Systolic BP (mmHg) 151.1 ± 24.4 156.3 ± 26.6 0.043
Diastolic BP (mmHg) 81.8 ± 15.7 81.3 ± 17.0 0.758
CVD/CHF, n (%) 34 (14.0) 45 (26.9) 0.001
Hemoglobin (g/dL) 8.6 ± 1.6 8.4 ± 1.7 0.335
BUN (mg/dL) 92.5 ± 32.3 104.5 ± 98.3 0.131
Creatinine (mg/dL) 10.3 ± 4.7 10.4 ± 5.6 0.874
Sodium (mmol/L) 137.2 ± 5.2 136.1 ± 5.9 0.054
Potassium (mmol/L) 5.0 ± 0.9 5.3 ± 1.2 0.014
Bicarbonate (mmol/L) 16.8 ± 4.2 14.4 ± 5.2 <0.001
Calcium (mg/dL) 7.5 ± 1.1 7.3 ± 1.5 0.897
Phosphorus (mg/dL) 6.3 ± 2.0 6.4 ± 2.5 0.499
Albumin (g/dL) 3.6 ± 0.6 3.5 ± 0.5 0.472
iPTH (pg/dL) 239.7 ± 178.5 235.5 ± 167.8 0.845
eGFR
C-G 7.7 ± 3.9 7.6 ± 3.7 0.728
Corrected C-G 7.9 ± 3.7 7.7 ± 3.4 0.538
MDRD 6.2 ± 3.4 6.3 ± 3.4 0.640
CKD-EPI 5.6 ± 3.2 5.6 ± 3.1 0.880
Nankivell 0.13 ± 12.19 0.06 ± 13.57 0.956
Reasons to start HD, n (%) <0.001
Fluid overload 76 (31.4) 81 (48.5)
Uremic symptoms 161 (66.5) 63 (37.7)
Hyperkalemia 3 (1.2) 13 (7.8)
Metabolic acidosis 2 (0.8) 10 (6.0)
BMI, body mass index; BP, blood pressure; BUN, blood urea nitrogen;
C-G, CockcrofteGault; CHF, congestive heart failure; CKD-EPI, Chronic
Kidney Disease Epidemiology Collaboration; CVD, cardiovascular dis-
ease; DM, diabetes mellitus; eGFR, estimated glomerular ﬁltration rate;
ER, emergency room; HD, hemodialysis; iPTH, intact parathyroid hor-
mone; MDRD, Modiﬁcation of Diet in Renal Disease.
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In the IDEAL study, dialysis was planned at an eGFR of 5e7
mL/min in the late-start group; however, three-fourth of the
patients could not delay the dialysis until this level because of
various symptoms including uremia (72.7%), ﬂuid overload
(8.7%), malnutrition (1.6%), and hyperkalemia (1.2%), which
results in dialysis initiation at a higher eGFR of 9.8 mL/min by
the corrected CockcrofteGault equation and 7.2 mL/min by the
MDRD equation [6]. Because most of our patients started HD
based on uremic symptoms and ﬂuid and electrolyte distur-
bances, it is reasonable to compare them with this late-start
group in the IDEAL study. We found that our patients started
dialysis at an eGFR of 7.8 mL/min by the corrected Cock-
crofteGault equation and 6.2 mL/min by the MDRD equation,
which are lower than the corresponding eGFR in the IDEAL
study by 2 mL/min. To exclude cases of early planned HD
initiation completely, we separately evaluated the patients who
started HD urgently in the ER. The eGFR of these patients were
7.7 mL/min by the corrected CockcrofteGault equation and 6.3
mL/min by the MDRD equation, which was similar to the eGFRs
of the total patients. The difference of eGFR between our pa-
tients and the IDEAL patients may indicate that either our pa-
tients develop symptoms at a lower GFR or report symptoms
later, as compared with patients in the West.
Fluid overload accounted for 38.4% of HD initiation, as
compared with 8.7% in the IDEAL study. This suggests thatsodium intake of our patients may be higher than that of
Western patients because of a higher content of sodium in
Korean food.
In addition, we evaluated the eGFR according to different
clinical situations: patients with DM versus without DM and
outpatient clinic patients versus ER patients. DM patients
started HD at a signiﬁcantly higher eGFR than non-DM
patients, which may be due to the higher proportion of ﬂuid
overload in DM (44.9%) than that in non-DM patients (31.4%).
In our experience, it is more difﬁcult to tolerate ﬂuid overload
than uremic symptoms. It is possible that the higher eGFR in
DM patients should contribute to the less-severe metabolic
acidosis, hyperphosphatemia, and hyperparathyroidism in
these patients. Accordingly, the United States Renal Data Sys-
tem (USRDS) data showed that the early initiation of dialysis is
associated with the presence of DM [14].
The patients who present to the ER are usually in more ur-
gent need of HD than clinic patients. Therefore, it is conceivable
that ER patients may have lower eGFR than the clinic patients.
However, we found that both groups were comparable in eGFR.
ER patients were older and had more disturbances of ﬂuid
balance, serum potassium, and serum bicarbonate levels, as
compared to clinic patients, which might explain the more
urgent need for dialysis in ER patients. The higher incidence of
CVDs/CHF in DM and ER groups should have contributed to the
higher proportion of volume overload as a reason for dialysis
start in these groups.
Lee et al / eGFR at hemodialysis initiation 211Regarding the equation that best deﬁnes the eGFR value at
HD initiation, our ﬁnding suggests that the corrected Cock-
crofteGault equation, which was adopted in the IDEAL study,
may best ﬁt the purpose because of its good correlations with
CKD-speciﬁc complications and the smallest dispersion (coef-
ﬁcient variation). In addition, our data indicate that the Nan-
kivell equations that were originally developed for kidney
transplants should not be used in CKD patients given its high
dispersion and irrelevance to CKD-speciﬁc complications. The
poor performance of the Nankivell equation may be explained
by its development from the transplant population and the
inclusion of blood urea nitrogen as one of the variables unlike
the other equations [13].
A limitation of this study is that we were not successful in
deﬁning the best eGFR in the subgroups such as DM or ER
groups because the reduced sample sizes of the subgroups
were not big enough to make the statistical analysis adequately
powered. Another limitation is that we do not have data on GFR
using 24-hour urine Cr clearance or radioisotope renal scans to
compare with each eGFR. A larger prospective study with the
actual measurement of GFR is required to better evaluate the
utility of various eGFRs at the time of HD initiation.
In summary, we showed that the mean eGFR at HD start was
signiﬁcantly different across the equations. The mean eGFR
ranged between 5.6 and 7.8 mL/min according to the 4 eGFR
equations, excluding the Nankivell equation. The Nankivell
equation was not suitable for CKD patients. The corrected
CockcrofteGault, the MDRD, and the CKD-EPI equations were
well correlated with all CKD-speciﬁc complications. The mean
eGFR by the corrected CockcrofteGault equation showed the
lowest dispersion among all equations. DM patients started HD
at a higher eGFR than non-DM patients, and the patients who
underwent emergent HD in ER did not differ in eGFR, as
compared with the nonemergent patients. This study was not
designed to evaluate the optimal timing of dialysis initiation;
hence, the eGFR in this study is not an indication for the initi-
ation of dialysis.
This study is potentially a valuable reference in the man-
agement of CKD patients and in the design of the future studies
for the optimal timing of dialysis initiation.
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